{"id":"W2896458230","doi":"10.1016/s1470-2045(18)30618-1","title":"Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"National Health and Medical Research Council; AstraZeneca Australia; Siemens; National Health Research Institutes; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Follicular lymphoma; Vincristine; Bendamustine; Rituximab; Internal medicine; Prednisone; Clinical endpoint; CHOP; Oncology; Cyclophosphamide; Surgery; Lymphoma; Gastroenterology; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005149356,0.001803751,0.002807889,0.0003739986,0.0004477657,0.001713307,0.001371058,0.002146214,0.003600921],"category_scores_gemma":[0.006341998,0.0005873213,0.003721088,0.000491751,0.001603352,0.001801052,0.0008798925,0.003333363,0.0006340517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00127519,"about_ca_system_score_gemma":0.0007804619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009015576,"about_ca_topic_score_gemma":0.001191652,"domain_scores_codex":[0.996722,0.002276682,0.0001186473,0.0004394494,0.0001279296,0.000315205],"domain_scores_gemma":[0.9932909,0.003427718,0.001459958,0.0007547544,0.0002001888,0.0008664391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9837158,0.0009600106,0.006047997,0.0002009041,0.002279193,0.00002075352,0.00003371026,0.0004913056,0.0008724364,0.00004559798,0.0002613438,0.00507094],"study_design_scores_gemma":[0.7483249,0.1612442,0.07260579,0.0001303225,0.01059419,0.0001576407,0.0001046617,0.002632326,0.001775059,0.001167077,0.001167881,0.00009596261],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951309,0.002324115,0.0003209976,0.0003336758,0.0001651123,0.0003455572,0.0006649292,0.00003614016,0.0006785968],"genre_scores_gemma":[0.9975957,0.0003377472,0.0002296375,0.0002238986,0.0001701466,0.000282449,0.000712137,0.00001405485,0.0004342071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005149356,"threshold_uncertainty_score":0.02723271,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03272674167592464,"score_gpt":0.3595032829152931,"score_spread":0.3267765412393684,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}